Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.26 HKD | -0.18% |
|
+1.44% | -61.89% |
06-27 | Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target is HK$14 | MT |
06-19 | Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.89% | 5.87B | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |
- Stock Market
- Equities
- 2269 Stock
- News WuXi Biologics (Cayman) Inc.
- Oxford BioTherapeutics Designates Second Bispecific Antibody Program Leveraging WuXi Biologics’ WuXiBody® Platform